WELL Health Technologies (TSE:WELL) Insider Eva Fong Sells 15,000 Shares

Key Points

• Eva Fong, an insider at WELL Health Technologies, sold 15,000 shares for a total of C$71,250 at an average price of C$4.75 on August 29th.
• Following the sale, Fong now holds 1,973,819 shares worth approximately C$9.4 million, indicating a 0.75% decrease in her position.
• The company's stock is currently down 0.9%, trading at C$4.61, with a 12-month range between C$3.68 and C$7.36.

WELL Health Technologies Corp. (TSE:WELL - ) insider Eva Fong sold 15,000 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of C$4.75, for a total value of C$71,250.00. Following the transaction, the insider owned 1,973,819 shares of the company's stock, valued at approximately C$9,375,640.25. This trade represents a 0.75% decrease in their position.

WELL Health Technologies Stock Down 0.9%

WELL stock traded down C$0.04 during trading hours on Tuesday, reaching C$4.61. 394,791 shares of the stock were exchanged, compared to its average volume of 928,862. The firm's 50-day moving average is C$4.70 and its 200-day moving average is C$4.50. The company has a market cap of C$1.17 billion, a price-to-earnings ratio of -9.60, a PEG ratio of -1.93 and a beta of 1.05. The company has a debt-to-equity ratio of 46.79, a current ratio of 1.14 and a quick ratio of 1.02. WELL Health Technologies Corp. has a 12 month low of C$3.68 and a 12 month high of C$7.36.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.